Avails Medical, Inc.

Avails Medical, Inc. is a medical technology company founded in 2013 by Stanford University alumni. The company focuses on addressing antimicrobial resistance through rapid diagnostic solutions. Its flagship product, the FDA-cleared eQUANT™ System, significantly reduces the time to actionable results for common gram-negative bacteria responsible for bloodstream infections, enabling faster treatment decisions. The core technology of Avails Medical is a patented electronic biosensor platform that provides reliable and easy-to-integrate diagnostic solutions for various healthcare settings. The eQUANT™ System accelerates the determination of bacterial susceptibility to antibiotics, helping clinicians avoid delays associated with traditional culture methods. The company targets healthcare providers, clinical laboratories, and hospitals, particularly in intensive care units, where rapid testing is crucial for effective antibiotic prescribing. Led by a multidisciplinary team with expertise in biology, medicine, and regulatory affairs, Avails Medical is committed to innovating and scaling rapid diagnostic technologies to improve patient outcomes and antibiotic stewardship in healthcare.

• Employees 49
• Founded 2013
• Total Funding $8663020